Answers are grounded in this paper and cite their sources.
HK gene delivery enhances the native angiogenic response to ischemia. Angiogenesis gene therapy with HK might be applicable to peripheral occlusive vascular disease.
No takes yet. Share an insight, caveat, or question.
Emanueli et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: